Review expert perspectives on the most clinically relevant data on myelodysplastic syndromes and myeloproliferative neoplasms presented at the 2020 ASH annual meeting.
In this commentary, 2 experts discuss their top presentation choices at ASH 2020 in MDS and MPNs with the most potential to impact clinical practice.
In this podcast episode, listen to Amy E. DeZern, MD, MHS, and Srdan Verstovsek, MD, PhD, discuss new data and studies in MDS and MPNs presented at ASH 2020.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.